Citation Impact
Citing Papers
Negative Feedback Exerted by cAMP-dependent Protein Kinase and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes
2004
Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4
2008 StandoutNobel
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Acromegaly
2006 Standout
Contributions of Protein Kinase A Anchoring Proteins to Compartmentation of cAMP Signaling in the Heart
2002
Inflammation and metabolic disorders
2006 StandoutNature
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
2006 Standout
Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor
2006
Microbial tryptophan catabolites in health and disease
2018 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious Canines
2004
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
The metabolic syndrome
2010 Standout
Glucagon-Like Peptide-1 Infusion Improves Left Ventricular Ejection Fraction and Functional Status in Patients With Chronic Heart Failure
2006
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
2008 Standout
Exendin‐4, a glucagon‐like protein‐1 (GLP‐1) receptor agonist, reverses hepatic steatosis in ob/ob mice†
2005
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The biology of incretin hormones
2006 Standout
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
2014
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3
2005
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins
2004
Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat Hearts
2006
The mitochondrial uncoupling-protein homologues
2005
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Mitochondria, Oxidants, and Aging
2005 Standout
Modeling β-Adrenergic Control of Cardiac Myocyte Contractility in Silico
2003
The metabolic syndrome
2005 Standout
Biology of Incretins: GLP-1 and GIP
2007 Standout
Free Fatty Acid-induced β-Cell Defects Are Dependent on Uncoupling Protein 2 Expression
2004
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
2003
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
β2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics
2007 StandoutNobel
The Physiology of Glucagon-like Peptide 1
2007 Standout
Myocardial Reperfusion Injury
2007 Standout
Negative regulation of β-adrenergic function by hydrogen sulphide in the rat hearts
2008
An immune origin of type 2 diabetes?
2005
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore
2004
Recurrent miscarriage
2006 Standout
Participation of JAK and STAT Proteins in Growth Hormone-induced Signaling
1996
Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has A Direct Role in Decreasing Hepatic Steatosis in Vitro by Modulating Elements of the Insulin Signaling Pathway
2010
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
2008 Standout
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
2009
Cardiac excitation–contraction coupling
2002 StandoutNature
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
2012
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
2003
Cardiovascular Biology of the Incretin System
2012
How mitochondria produce reactive oxygen species
2008 Standout
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Effects of exposure to environmental tobacco smoke on reproductive health.
2002
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
2009
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Cardiac Function in Mice Lacking the Glucagon-Like Peptide-1 Receptor
2003
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Compartmentation of Cyclic Nucleotide Signaling in the Heart
2006
Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy
2004
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Cardiovascular Actions of Incretin-Based Therapies
2014
Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin
2009
Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury
2005
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
What Is the Role of β-Adrenergic Signaling in Heart Failure?
2003
Works of Xiaolin Wang being referenced
Mitochondrial Functional State in Clonal Pancreatic β-Cells Exposed to Free Fatty Acids
2003
Prospective study of exposure to environmental tobacco smoke and dysmenorrhea.
2000
Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes
2001
Growth hormone (GH) induces tyrosine-phosphorylatedproteins in mouse L cells that express recombinant GH receptors.
1994